Robuta

https://www.alnylam.com/ The Leading RNAi Therapeutics Company | Alnylam Alnylam has pioneered RNAi therapeutics, an innovative approach to gene silencing. We are driven by science and committed to developing transformational... leadingrnaitherapeuticscompanyalnylam https://www.rnaiscience.com/ Alnylam Medical Information for US Healthcare Professionals | Alnylam RNAi Science - US us healthcare professionalsmedical informationalnylamrnaiscience https://www.alnylam.com.br/ Alnylam® Pharmaceuticals | Principal Empresa de Terapia de RNAi | Brasil A Alnylam está liderando a tradução da Interferência de RNA (RNAi) em uma classe de medicamentos totalmente inovadora, que acreditamos ter o potencial de... pharmaceuticalsprincipalempresadeterapia https://www.alnylam.ca/ Alnylam® Pharmaceuticals—The Leading RNAi Therapeutics Company | Canada Alnylam is leading the translation of RNA interference (RNAi) into a innovative, entirely new class of medicines which we believe have the potential to... leadingrnaitherapeuticscompanycanada https://cordis.europa.eu/article/id/113333-engineered-adenovirus-armed-with-specific-rnai-networks-kills-selectively-tumor-cells Engineered adenovirus armed with specific RNAi networks kills selectively tumor cells | News |... p53, the so-called "guardian of the genome", is the most commonly dysfunctional gene in human cancers, due to mutations in the gene... https://www.rnaiscience.com/congresses-publications/american-association-study-liver-diseases-AASLD-2025 American Association for the Study of Liver Diseases (AASLD) 2025 | Alnylam RNAi Science - US American Association for the Study of Liver Diseases (AASLD) 2025 | Washington, D.C. . Please view American Association for the Study of Liver Diseases (AASLD)... https://ssbd.riken.jp/database/dataset/203/ SSBD - SSBD:database - RNAi_T12D8.6_071101_01 databasernai https://www.biotechsnap.com/p/novartis-rnai-argo-deal Novartis doubles down on RNAi heart drugs with $160M Argo deal Novartis expands RNAi cardiovascular strategy with $160M Argo deal, targeting innovative gene-silencing therapies to transform heart disease treatment globally. novartisdoublesrnai https://library.rvc.ac.uk/GroupedWork/365112dd-3162-66fe-b83e-c820e5e9ce6d-eng/Home RNAi for plant improvement and protection | Royal Veterinary College This book contains a series of chapters reviewing the current scientific knowledge on RNAi, methods for developing RNAi systems in transgenic plants and a... for plantrnaiimprovementprotectionroyal https://medicaex.com/prnewswire/sirnaomics-dosed-the-first-patient-in-phase-i-clinical-study-of-galnac-based-rnai-therapeutic-stp122g-for-anticoagulant-treatment/ Sirnaomics Dosed the First Patient in Phase I Clinical Study of GalNAc-Based RNAi Therapeutic... Jun 2, 2023 - HONG KONG, Germantown, Md. and Suzhou, China, June 2, 2023 /PRNewswire/ -- Sirnaomics Ltd. (the "Company"; together with its subsidiaries, the "Group" or https://www.consultantlive.com/view/zilebesiran-rnai-for-hypertension-heads-to-phase-3-cardiovascular-outcomes-trial Zilebesiran, RNAi for Hypertension, Heads to Phase 3 Cardiovascular Outcomes Trial Alnylam Pharmaceuticals debuts phase 2 KARDIA-3 data at ESC 2025 and advances zilebesiran into a phase 3 outcomes trial. zilebesiranrnaihypertensionheads https://research-portal.uu.nl/en/activities/rnai-based-silencing-in-fungi-3/ RNAi-based silencing in Fungi - Utrecht University rnaibasedsilencingfungiutrecht https://www.proteinspire.org/shop/abm-ls410336-2010111i01rik-set-sirna-shrna-rnai-lentivector-mouse-39212 2010111I01Rik-set siRNA/shRNA/RNAi Lentivector (Mouse) | anticorps setsirnashrnarnailentivector https://rnaibased-therapeutics.com/speaker/andrew-fraley/ Andrew Fraley - 7th RNAi-Based Therapeutics Summit Jan 22, 2026 - Andrew Fraley is the Founding and Managing Partner of Sunrise BioVentures. A prolific company builder, he is a serial entrepreneur and scientific innovator... andrewrnaibasedtherapeuticssummit https://armatusbio.com/ Armatus | Vectorized RNAi for rare neuromuscular disease Armatus Bio is raising expectations for FSHD with precision gene therapy. rare neuromusculararmatusvectorizedrnaidisease https://www.frontiersin.org/research-topics/70314/25-year-anniversary-of-rnai-for-pest-management-milestones-and-prospects/articles Frontiers | 25-Year Anniversary of RNAi for Pest Management: Milestones and Prospects Over 25 years have elapsed since gene regulation by RNA interference (RNAi) was described by Fire and Mello. During this time mechanisms of RNAi were defined... https://rnaibased-therapeutics.com/ Home - 7th RNAi-Based Therapeutics Summit The 7th RNAi-Based Therapeutics Summit is the only event uniting the RNA interference ecosystem to translate the next wave of siRNA and microRNA drugs rnaibasedtherapeuticssummit https://www.sigmaaldrich.com/DK/en/products/molecular-biology-and-functional-genomics/gene-editing-and-functional-genomics/rnai-single-clones RNAi Single Clones Genome-wide human and mouse shRNA clones from the TRC1.5 and TRC2 collections, available as plasmids or high-titer virus. rnaisingleclones https://oligotherapeutics.org/galnac-sirna-conjugates-leading-the-way-for-delivery-of-rnai-therapeutics/ GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics - Oligonucleotide... Nov 8, 2021 - Springer AD, Dowdy SF. Nucleic Acid Ther. 2018 Jun;28(3):109-118. PubMed leading the way https://www.proteinspire.org/shop/abm-ls410164-1700016h13rik-set-sirna-shrna-rnai-lentivector-mouse-37482 1700016H13Rik-set siRNA/shRNA/RNAi Lentivector (Mouse) | anticorps setsirnashrnarnailentivector https://www.origene.com/ Validated Antibodies, cDNA Clones, Lentivirus, RNAi | OriGene Technologies Inc. OriGene is a global leader in providing high-quality reagents to support genomic and proteomic research, including cDNA clones, antibodies, recombinant... cdna clonesorigene technologiesvalidatedantibodieslentivirus https://pubchem.ncbi.nlm.nih.gov/bioassay/1671195 AID 1671195 - Genome-wide RNAi Screen for Regulators of LDLR Activity - PubChem BioAssay record AID 1671195 submitted by Fernandez-Hernando Lab, Department of Comparative Medicine, Yale University: Genome-wide RNAi Screen for Regulators of... https://edoc.mdc-berlin.de/id/eprint/14022/ An RNAi-based approach to down-regulate a gene family in vivo - MDC Repository https://curf.clemson.edu/technology/fusogenic-peptides-for-delivery-of-rnai-therapeutics-to-ovarian-cancer-2/ Fusogenic Peptides for Ovarian Cancer RNAi Therapy - CURF Mar 27, 2026 - Innovative fusogenic peptides enhance RNAi therapy delivery, improving targeted ovarian cancer treatment for greater efficacy and precision. ovarian cancerpeptidesrnaitherapy https://www.biologicspd.com/shop/fm-13778150-lipofectamine-rnai-max-11919?category=36 Lipofectamine RNAi MAX | Biologic Process Development rnaimaxbiologicprocessdevelopment https://iris.uniupo.it/handle/11579/19979 RNAi technology and lentiviral delivery as a powerful tool to suppress Tpr-Met-mediated... https://www.switchthera.com/ Revolutionizing RNAi Therapies | Switch Therapeutics Apr 8, 2025 - Switch Therapeutics is a biotech company dedicated to revolutionizing RNA interference (RNAi) therapies with conditionally activated siRNAs (CASi). revolutionizingrnaitherapiesswitchtherapeutics https://data.rnaiscience.com/congresses/pediatric-academic-societies-2026?site=us PAS 2026: Pediatric Academic Societies | Alnylam RNAi Science Data Hall Pediatric Academic Societies 2026 | Boston, MA, USA. View selected Alnylam scientific information presented at PAS 2026. Connect with Alnylam Medical... academic societiesscience datapaspediatricalnylam https://www.atopixtherapeutics.com/shop/boc-0523-10-adenovirus-cmv-rnai-51473 ADENOVIRUS-CMV-RNAI | Atopix adenoviruscmvrnai https://ssbd.riken.jp/database/dataset/133/ SSBD - SSBD:database - RNAi_F58A4.3_040803_02 databasernai https://www.natap.org/2014/HBV/011315_02.htm Arrowhead Files IND for RNAi Therapeutic ARC-520 to Begin Phase 2b Multiple-Dose Studies in Chronic... https://www.protocol-online.org/biology-forums/posts/40641.html confusion about off-target effect - siRNA, microRNA and RNAi about offconfusiontargeteffectsirna https://eshop.biogen.cz/kits-for-dsrnarnai-synthesis Kits for dsRNA/RNAi Synthesis kitsrnaisynthesis https://pubmed.ncbi.nlm.nih.gov/41544794/ RNAi therapy targeting coronavirus genomes, pulmonary delivery strategies and design principles: A... With the persistent global outbreak of Coronavirus Disease 2019 (COVID-19), the development of effective antiviral strategies has become a top priority in... https://www.natap.org/2020/AASLD/AASLD_87.htm HBV RNAi inhibitor RG6346 in Phase 1b-2a trial was safe, well-tolerated, and resulted in... https://finviz.com/news/282211/silexion-therapeutics-to-attend-7th-annual-rnai-based-therapeutics-summit Silexion Therapeutics to Attend 7th Annual RNAi-Based Therapeutics Summit Stock screener for investors and traders, financial visualizations. to attendtherapeuticsannualrnaibased https://www.alliedacademies.org/abstract/designer-sirnas-to-overcome-the-challenges-from-the-rnai-pathway-4424.html Designer siRNAs to overcome the challenges from the RNAi pathway | Abstract Small interfering RNA (siRNA)-based technology is playing a pivotal role in understanding gene function. Huge siRNA libraries coupled to high-content .. the challengesdesignerovercomernaipathway https://www.nature.com/articles/s41467-025-60497-8?error=cookies_not_supported&code=ad9dace4-4a2f-4020-a997-64b26e56bcc3 AAV-based delivery of RNAi targeting ataxin-2 improves survival and pathology in TDP-43 mice |... Oct 23, 2025 - Amyotrophic lateral sclerosis (ALS) involves motor neuron death due to mislocalized TDP-43. Pathologic TDP-43 associates with stress granules (SGs), and... https://www.clinicaltrialsarena.com/events/2nd-annual-rnai-based-therapeutics-summit-june-2021-digital-event/ 2nd Annual RNAi-Based Therapeutics Summit - June 2021 - Digital Event - Clinical Trials Arena https://www.protocol-online.org/prot/Molecular_Biology/RNA/RNA_Interference__RNAi_/index.html RNA/RNA Interference (RNAi) Protocols RNA interference protocols rna interferencernaiprotocols https://urgi.versailles.inrae.fr/faidare/studies/dXJuOkVWQS9zdHVkeS9QUkpOQTM3Mzg5MA== Study : Gossypium hirsutum L. cv. Coker 312 phytochrome A1(PHYA1) RNAi line cotton boll total RNA https://www.rnaiscience.com/search?query=amyloidosis&page=1 Search Medical Information & Resources | Alnylam RNAi Science - US search medical informationresourcesalnylamrnaiscience https://www.pfsa.be/shop/abm-ls410018-0610037l13rik-set-sirna-shrna-rnai-lentivector-mouse-36029 0610037L13Rik-set siRNA/shRNA/RNAi Lentivector (Mouse) | Plate Form SA setsirnashrnarnailentivector https://www.researchandmarkets.com/report/united-arab-emirates-rnai-therapy-market United Arab Emirates RNAi Therapeutics Market Size & Trends United Arab Emirates RNAi Therapeutics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 united arab emiratesmarket sizernaitherapeuticstrends https://www.watchacrestv.com/videos/vorceed-enlist-corn Enlist Corn RNAi Technology | Corteva - Seed - AcresTV Corteva Enlist corn brings a brand-new mode of action to control corn rootworm larvae in your corn while also stacking multiple new modes of action for... enlistcornrnaitechnologycorteva https://ssbd.riken.jp/database/dataset/246/ SSBD - SSBD:database - RNAi_Y37D8A.14_041109_02 databasernai https://ricerca.uniba.it/handle/11586/128522 Inhibition of aquaporin-4 expression in astrocytes by RNAi determines alteration in cell... https://www.immunecentral.com/shop/171-i023308-snord116-set-sirna-shrna-rnai-lentivect-10015 SNORD116@-set siRNA/shRNA/RNAi Lentivect | Immune Central setsirnashrnarnaiimmune https://www.protocol-online.org/biology-forums/siRNA--microRNA-and-RNAi/more16.html - siRNA--microRNA-and-RNAi sirnamicrornarnai https://www.indianperson.com/tag/antisense-rnai-therapeutics-market-future/ Antisense & RNAi Therapeutics Market future Archives - Jan Sewa future archivesrnaitherapeuticsmarketjan https://www.rnaiscience.com/search?query=diagnosis Search Medical Information & Resources | Alnylam RNAi Science - US search medical informationresourcesalnylamrnaiscience https://www.prnewswire.com/news-releases/the-global-antisense-and-rnai-therapeutics-market-size-is-expected-to-reach-usd-1-81-billion-by-2025--300797334.html The global antisense and RNAi therapeutics market size is expected to reach USD 1.81 billion by 2025 https://galleon-stage.synthego.com/blog/rnai-vs-crispr-guide/ RNAi vs. CRISPR: Guide to Selecting the Best Gene Silencing Method Oct 10, 2025 - RNAi and CRISPR interrogate gene function by blocking gene expression and analyzing its effect on phenotype. RNAi silences genes by generating knockdowns at... guide tothe bestgene silencingrnaivs https://www.sanegenebio.com/ RNAi Therapies for Metabolic and Autoimmune Diseases Mar 30, 2026 - Revolutionizing RNAi therapies for metabolic and autoimmune diseases through its Ligand and Enhancer Assisted (LEAD™) Technology. rnaitherapiesmetabolicautoimmunediseases